Literature DB >> 10723797

Intracellular adapter molecules.

L A Norian1, G A Koretzky.   

Abstract

Lymphocyte antigen receptor engagement leads to the initiation of numerous signal transduction pathways that direct ultimate cellular responses. In recent years, it has become apparent that adapter molecules regulate the coupling of receptor-proximal events, such as protein tyrosine kinase activation, with end results such as inducible gene expression and cytoskeletal rearrangements. While adapter molecules possess no intrinsic enzymatic activity, their ability to mediate protein-protein interactions is vital for the integration and propagation of signal transduction cascades in lymphocytes. Recent studies demonstrate that intracellular adapter molecules function as both positive and negative regulators of lymphocyte activation.

Mesh:

Substances:

Year:  2000        PMID: 10723797     DOI: 10.1006/smim.2000.0206

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  4 in total

1.  The adapter molecule Sin regulates T-cell-receptor-mediated signal transduction by modulating signaling substrate availability.

Authors:  Luzhou Xing; Laura T Donlin; Rebecca H Miller; Konstantina Alexandropoulos
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

2.  Adaptor FYB (Fyn-binding protein) regulates integrin-mediated adhesion and mediator release: differential involvement of the FYB SH3 domain.

Authors:  L Geng; S Pfister; S K Kraeft; C E Rudd
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

3.  Grap negatively regulates T-cell receptor-elicited lymphocyte proliferation and interleukin-2 induction.

Authors:  Randy Shen; Ying-Bin Ouyang; Cheng-Kui Qu; Andres Alonso; Lindsey Sperzel; Tomas Mustelin; Mark H Kaplan; Gen-Sheng Feng
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

Review 4.  SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels.

Authors:  Ulrike Lorenz
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.